key: cord-0760873-k6lb5o98 authors: Zuckerman, N. S.; Fleishon, S.; Bucris, E.; Bar-Ilan, D.; Linial, M.; Bar-Or, I.; Indenbaum, V.; Weil, M.; Israel National Consortium for SARS-CoV-2 sequencing,; Mendelson, E.; Mandelboim, M.; Mor, O. title: A unique SARS-CoV-2 spike protein P681H strain detected in Israel date: 2021-03-28 journal: nan DOI: 10.1101/2021.03.25.21253908 sha: 85f0209d4c54a0e07bcdeb1482d8f7e12cedab9d doc_id: 760873 cord_uid: k6lb5o98 Routine detection, surveillance and reporting of SARS-CoV-2 novel variants is important, as these threaten to hinder vaccination efforts. Herein we report a local novel strain that includes a non-synonymous mutation in the spike (S) protein - P681H and additional synonymous mutations. The P681H Israeli strain has not been associated with higher infection rates and was neutralized by sera from vaccinated individuals in comparable levels to the B.1.1.7 strain and a non-P681H strain from Israel. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is in the midst of its third wave in Israel, with increasing efforts to sequence complete SARS-CoV-2 genomes to detect known and emerging variants. Herein we report a local novel strain that includes a non-synonymous mutation in the spike (S) protein -P681H and additional synonymous mutations. The P681H Israeli strain has not been associated with higher infection rates and was neutralized by sera from vaccinated individuals in comparable levels to the B.1.1.7 strain and a non-P681H strain from Israel. The P681H strain presents as a cluster in a phylogenetic tree of all sequenced samples in Israel, distinct from the B.1.1.7 Pangolin lineage, which also contains the P681H mutation ( Figure 1A ). The strain originates from the B.1.1.50 Pangolin lineage, in which the majority of the sequences are from Israel (70%), Palestine (12%) and the UK (12%) [1] . It is characterized by a non-synonymous mutation in the S protein -P681H (C23604A) and additional four synonymous mutations: Nsp3:C7765T, Nsp12b:C13821T, Nsp16:T21111C and C29545A. The strain carrying these mutations is unique to Israel, aside for 2 sequences originating in Palestine. A sub-clade of the strain contains an additional non-synonymous mutation in the S protein -A27S (G21641T) ( Figure 1B) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint Until January 2021, an overall of 181 individuals were infected with the P681H strain. These were mostly randomly sampled from districts from all over Israel, with no gender or age bias (Table 1) . The P681H mutation was also frequently identified by SARS-CoV-2 whole genome sequencing of samples from waste-water treatment plants in 9 locations across Israel, that were collected once a month, August 2020 -January 2021 ( Figure 1 ). As the P681H mutation is also found in the B.1.1.7 variant, its frequency has increased in some locations since late December 2020, following the first introduction of B.1.1.7 into Israel. Notably, the mutation was already observed with 5% frequency as early as October 2020 in Rahat (city in the South of Israel) and in November, at a frequency of 98% in Natanya and Haifa, located at the center and north of Israel, respectively ( Figure 2 ). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint The neutralization potency of antibodies against the local P681H strain was compared to the neutralization of other strains circulating in Israel. VERO-E6 cells were infected with (a) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. The P681H mutation has been observed as early as March 2020 in samples worldwide, e.g. in Nigeria [3] and Hawaii [4] and also characterizes the globally spreading B.1.1.7 variant. Herein, we report 181 sequences that are part of the B.1.1.50 lineage, but form a unique local strain that harbors the P681H mutation along with additional defining mutations. The is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint assays for VSV-based SARS-CoV-2 pseudoviruses expressing the S protein with the P681H mutation demonstrated no significant changes in the titer required for neutrazliation compared to the unmutated S protein [4] . Additionally, no significant changes in the titer were needed for neutralization of the WT SARS-CoV-2 compared to a viral sample from the B.1.1.7 lineage (in which P681H is one of its defining mutations), using sera from convalescent patients or individuals vaccinated with the mRNA-1273 vaccine from Moderna [5] . Similar to these reports, this study demonstrates comparable neutralization of the P681H Israel strain, non-P681H strain and the B.1.1.7 variant by sera from vaccinated individuals. Overall, as the P681H local strain was neutralized as efficiently as commonly circulating strains, was not associated with escalated infection or spread and given that the P681H mutation is observed in additional SARS-CoV-2 strains worldwide, this emerging local variant is currently not defined as a variant of concern. Nevertheless, it is still monitored by routine next generation sequencing in Israel. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint Random sampling and collection of SARS-CoV-2 PCR-positive samples for sequencing complete viral genomes is routinely conducted in Israel as part of a national effort for monitoring SARS-CoV-2 variants, starting December 2020. Viral genomes were extracted from 200µl respiratory samples with the MagNA PURE 96 (Roche, Germany), according to the manufacturer instructions. Libraries were prepared using COVID-seq library preparation kit, as per manufacturer's instructions (Illumina). Library validation and mean fragment size was determined by TapeStation 4200 via DNA HS D1000 kit (Agilent). Libraries were pooled, denatured and diluted to 10pM and sequenced on NovaSeq (Illumina). Fastq files were subjected to quality control using FastQC (www.bioinformatics.babraham.ac.uk/ projects/fastqc/) and MultiQC [6] and low-quality sequences were filtered using trimmomatic [7] . Sequences were mapped to the SARS-CoV-2 reference genomes (NC_045512.2) using Burrows-Wheeler aligner (BWA) mem [8] . Resulting BAM files were sorted, indexed and subjected to quality control using SAMtools suite [9] . Coverage and depth of sequencing was calculated from sorted bam files using a custom python script. A consensus sequence was constructed for each sample using iVar (https://andersen-lab.github.io/ivar/html/index.html), where positions with <5 nucleotides were determined as Ns, and converted to a fasta file using seqtk (https://github.com/lh3/seqtk). Sequences were aligned to SARS-CoV-2 reference genome (NC_045512.2) using MAFFT [10] . Mutation calling, translation to amino acid and identification of P681H variant sequences were done in R with a custom code using Bioconductor package Seqinr [11] . Sequences were further analyzed together with additional sequences identified as belonging to the background lineage B.1.1.50 downloaded from GISAID [12] . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint Phylogenetic trees were constructed using the Augur pipeline [2] . Sequences were aligned to SARS-CoV-2 reference genome (NC_045512.2) using MAFFT [10] , and a time-resolved phylogenetic tree was constructed with IQ-Tree [13] and TreeTime [14] under the GTR substitution model and visualized with auspice [2] . Lineage nomenclature was attained from Pangolin Lineages [15] . Analysis of sewage samples was conducted using a custom R code and the Bioconductor package Rsamtools [16] . BAM files were imported to R and the frequency of each mutated position along the genome, out of the total number of nucleotides covering that position, was obtained. The frequency in position 681 in the spike protein was recorded for each sample. VERO-E6 cells at concentration of 20*103/well were seeded in sterile 96-wells plates with 10% FCS MEM-EAGLE medium, and stored at 37⁰C for 24 hours. One hundred TCID50 of P681H variant, non-P681H and B.1.1.7 isolates were incubated with inactivated sera diluted 1:10 to 1:1280 in 96 well plates for 60 minutes at 33ºC. Virus-serum mixtures were added to the Vero E-6 cells and incubated for five days at 33ºC, after which Gentain violet staining (1%) was used to stain and fix the cell culture layer. Neutralizing dilution of each serum sample was determined by identifying the well with the highest serum dilution without observable cytopathic effect. A dilution equal to 1:10 or above was considered neutralizing. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Nextstrain: real-time tracking of pathogen evolution The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant MultiQC: Summarize analysis results for multiple tools and samples in a single report Trimmomatic: a flexible trimmer for Illumina sequence data Fast and accurate long-read alignment with Burrows-Wheeler transform A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform SeqinR 1.0-2: A Contributed Package to the R Project for Statistical Computing Devoted to Biological Sequences Retrieval and Analysis GISAID: Global initiative on sharing all influenza data -from vision to reality IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies TreeTime: Maximum-likelihood phylodynamic analysis A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Rsamtools: Binary alignment (BAM), FASTA, variant call (BCF), and tabix file import It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted March 28, 2021. ; https://doi.org/10.1101/2021.03.25.21253908 doi: medRxiv preprint